Capabilities

In re Generic Pharmaceuticals Pricing Antitrust Litigation

Generic Drug Manufacturer
2016 - Ongoing

Our attorneys are defending a generic drug manufacturer in In re Generic Pharmaceuticals Pricing Antitrust Litigation, MDL 2724 (ED Pa). This complex litigation comprises multiple direct and indirect purchaser actions, as well as actions brought by a number of states, seeking damages for alleged price fixing and market allocation affecting generic drugs. Motions to dismiss are pending in a number of the actions, and discovery is in its early stages in this evolving litigation.

Email Disclaimer